Company intelligence / Profile preview

Invex Therapeutics Ltd

Perth, Western Australia, Australiainvextherapeutics.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Completed Phase 2 trial with strong results showing sustained drug effect in IIH population with no safety or toxicity concerns over 12 weeks of daily treatment. Currently conducting Phase 3 clinical trials in the UK, Europe, and Australia.

Therapeutic areas: Neurology
Modalities: Small molecule (repurposed drug)
Industry: Biotech

Drug pipeline

1 asset

Presendin

Beyond the preview

Go deeper on Invex Therapeutics Ltd.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invex Therapeutics Ltd.

Explore the full profile